October 22, 2006
Systems Analytics Participates the FDA’s Micro Array Quality Control (MAQC) Research Program
Systems Analytics Inc. (SAI) has announced today its participation to the FDA’s Micro Array Quality Control (MAQC) Research Phase II Program to support its toxicogenomics and clinical data analysis activities.
The MAQC project was established to generate a set of quality control tools and standards for the microarray research community and advance pharmacogenomics and bioinformatics for more effective medicines and medical products. The project involved 137 participants representing 51 organizations, including the FDA, NIH, EPA and USDA, all major whole-genome gene expression platform providers as well as several alternative gene expression platform providers. MAQC included validated reference samples, a large collection of multiplatform reference datasets as well as analysis tools.